drugset / Trial / NCT00144664
Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an open-label, Phase III study to evaluate the efficacy, safety and PK of MRA in patients with pJIA.
Timeline
- Start
- 2004-11
- Primary completion
- 2005-04
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tocilizumab | Monoclonal antibody | — | — |